Lenvatinib in severe hypoglycemia associated with hepatocelular carcinoma
| Autor: | Matías Estévez Escobar, Carmen Molina Villalba, Katherine Milagros Gómez Torres |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Sorafenib
medicine.medical_specialty Cirrhosis business.industry Gastroenterology General Medicine Hypoglycemia medicine.disease Severe hypoglycemia digestive system diseases chemistry.chemical_compound chemistry Hepatocellular carcinoma Internal medicine medicine Carcinoma Lenvatinib business Glycemic medicine.drug |
| Zdroj: | Revista Española de Enfermedades Digestivas. |
| ISSN: | 1130-0108 |
| Popis: | We present the case of a 24-year-old man with multicentric hepatocellular carcinoma over HBV cirrhosis treated with Sorafenib and Tenofovir. He comes to our center for repeated episodes of symptomatic hypoglycemia that cannot be managed with standard measures. After ruling out different possibilities, the suspicion of hypoglycemia due to a non-islet cell tumor was finally confirmed. Given the impossibility of a curative treatment due to a reduced functional reserve, Sorafenib was changed to Lenvatinib, thereby improving glycemic control. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|